Patients and Methods
Forty-eight patients suffering from Peyronie’s disease active phase
symptoms were included in the study. Methylprednisolone was administered
intralesionally for 8 weeks, once per week, at a dose of 40 mg. The
injection was applied into the plaques, which causes maximum curvature.
Patients were evaluated before and after treatment for plaque size,
angle of curvature, and erectile dysfunction according to the
International Index of Erectile Function-5 and Peyronie’s Disease
Questionnaire.